Produktname:5-Bromo-2-(trifluoromethoxy)aniline

IUPAC Name:5-bromo-2-(trifluoromethoxy)aniline

CAS:886762-08-9
Molekulare Formel:C7H5BrF3NO
Reinheit:98%
Katalognummer:CM118425
Molekulargewicht:256.02

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM118425-100g in stock ŮŽ
CM118425-500g in stock ijijƴ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:886762-08-9
Molekulare Formel:C7H5BrF3NO
Schmelzpunkt:-
SMILES-Code:NC1=CC(Br)=CC=C1OC(F)(F)F
Dichte:
Katalognummer:CM118425
Molekulargewicht:256.02
Siedepunkt:230.2°C at 760 mmHg
Mdl-Nr.:MFCD04039242
Lagerung:Keep in dark place, store at 2-8°C.

Column Infos

Onvansertib
Polo-like kinase 1 (PLK1) is a key regulator of the cell-cycle progression found in human cancers, and a potential therapeutic target for oncology drug development. The recent journal Clinical Cancer Research details the Phase 1b Study of Onvansertib in combination with chemotherapy+bevacizumab treatment for patients with patients with KRAS-mutated metastatic colorectal cancer (mCRC).
Cardiff Oncology’s novel inhibitor, Onvansertib effectively targets PLK1, that prevents from tumor cell growth. It aids restore DNA damage and promote the efficacy of the standard of care therapy in a number of indications.

Related Products